Variable | Overall sample (N = 130) | Rosuvastatin (n = 48) | Aspirin (n = 40) | Placebo (n = 42) |
---|---|---|---|---|
 | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) |
Age (years) | 20·2 (2·6) | 20·0 (2·7) | 20·7 (2·7) | 20·0 (2·4) |
BMI | 25·8 (7·6) | 24·3 (6·9) | 25·3 (8·1) | 27·6 (7·4) |
 | N (%) | N (%) | N (%) | N (%) |
Gender | ||||
 Female | 77 (59·2) | 28 (58·3) | 25 (62·5) | 24 (57.1) |
Age (younger than 18) | 29 (22·3) | 13 (27·1) | 8 (20·0) | 8 (19·0) |
English first language | 119 (91·5) | 44 (91.7) | 38 (95·0) | 37 (88·1) |
Occupationb | ||||
 Student | 55 (42·3) | 22 (45·8) | 16 (40·0) | 17 (40·5) |
 Full-time employment | 8 (6·2) | 3 (6·3) | 3 (7·5) | 2 (4·8) |
 Part time/ Casual | 36 (27·7) | 14 (29·2) | 11 (27·5) | 11 (26·2) |
 unemployed | 28 (21·5) | 8 (16·7) | 11 (27·5) | 9 (21·4) |
Living statusc | ||||
 Parents | 82 (63·1) | 25 (52·1) | 26 (65·0) | 31 (73·8) |
 Friends | 16 (12·3) | 8 (16·7) | 4 (10·0) | 4 (9·5) |
 Spouse/ De facto | 12 (9·2) | 5 (10·4) | 6 (15·0) | 1 (2·4) |
 Alone | 5 (3·8) | 3 (6·3) | 2 (5·0) | 0 (0·0) |
Psychosocial therapy during lifetime (yes) | 111 (85·4) | 40 (83·3) | 34 (85·0) | 37 (88·1) |
Ongoing psychological therapy during study (yes) | 90 (69.2) | 31 (64.6) | 31 (77.5) | 28 (66.7) |
Antidepressant use (yes) | 109 (83·0) | 37 (77·1) | 35 (87·5) | 37 (88·1) |
Ongoing antidepressant use during study (yes) | 39 (30·0) | 13 (27·1) | 14 (35·0) | 12 (28·6) |
CSSRS – past month | ||||
 Suicidal ideation | 124 (95·4) | 46 (95·8) | 38 (95·0) | 40 (95.2) |
 Suicidal behaviors | 10 (7·7) | 3 (6·3) | 5 (12·5) | 2 (4·8) |
 Suicidal acts | 6 (4·6) | 2 (4·2) | 3 (7·5) | 1 (2·4) |
 Non-suicidal self-injury | 23 (17·7) | 10 (20·8) | 6 (15·0) | 7 (16·7) |
Number of major | ||||
 Depressive episodes | 3 (1, 6) | 3 (3, 6) | 2 (1, 6) | 4 (2, 8) |
 Duration, weeks | 24 (12, 52) | 20 (20, 44) | 32 (16, 80) | 26 (12, 39) |
 Anxiety disorder | 81 (62·3) | 31 (64·6) | 28 (70·0) | 22 (52·4) |
 Substance use disorder | 17 (13·1) | 7 (14·6) | 4 (10·0) | 6 (14·3) |
Number of concomitant medications (median, IQR) | 3 (2, 5) | 3 (2, 4·25) | 3 (2, 5) | 4.5 (2, 6) |